YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer pens $10.6B acquisition

Posted online

Pfizer Inc. announced it would buy Array Biopharma for $16.4 billion in cash.

Array makes approved treatments for skin cancer.

"(The acquisition) sets the stage to create a potentially industry-leading franchise for colorectal cancer alongside Pfizer's existing expertise in breast and prostate cancers," Pfizer CEO Albert Bourla said.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences